Take Home Share
TAKE HOME SALES | | | | |
52 w/e 18 June 2017 |
|
|
|
|
|
VALUE |
VOLUME |
|
£m |
% y-o-y |
Packs (m) |
% y-o-y |
Cold Treatments |
92.0 |
8.7% |
38.0 |
6.3% |
Cough/Throat Lozenges |
74.8 |
-0.6% |
76.2 |
-3.0% |
Cough Liquids |
74.0 |
1.6% |
22.3 |
-3.2% |
Decongestants |
73.2 |
7.5% |
25.0 |
6.3% |
Total Category |
314.0 |
4.4% |
161.7 |
0.4% |
- With a chilly autumn last year, and following a fairly unsuccessful season, 2016/7 has seen year-on-year growth of £13.2m. There are 336k fewer shoppers now buying compared with two years earlier; prices have reached their highest levels since 2013.
- Demand has risen for products offering multiple benefits; cold and flu tablets and capsules have driven growth.
- Own label has been the big winner, driven by Tesco and Aldi’s capsule format. The Day and Night Nurse brand has been successful in pushing more expensive packs through pharmacy.
- Decongestants have also performed well while prices have increased 1.4% year on year. The subsector has been driven by Otrivine sprays and Calpol’s Vapour Plug NPD.
Stephanie Filletti, Kantar Worldpanel